The average brokerage recommendation (ABR) for Novo Nordisk (NVO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback